# Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects

> **NCT05244148** · NA · TERMINATED · sponsor: **Church & Dwight Company, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Common Cold
- Nasal Congestion

## Interventions

- **DEVICE:** IP1 - Stérimar BLOCKED NOSE Baby nasal spray
- **DEVICE:** IP2 - Stérimar Stop & Protect Cold Baby + standard of care
- **BEHAVIORAL:** Standard of Care

## Key facts

- **NCT ID:** NCT05244148
- **Lead sponsor:** Church & Dwight Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-25
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-03-20
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Unable to recruit 300 subjects.
- **Last updated:** 2024-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05244148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05244148, "Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05244148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*